BLU-U

DEVICE3 trials

Sponsors

DUSA Pharmaceuticals, Inc.

Conditions

Actinic KeratosisKeratosis, Actinic

Phase 2

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

CompletedNCT02239679

DUSA Pharmaceuticals, Inc.Actinic Keratosis

Start: 2014-09-30End: 2016-09-30Updated: 2018-08-24

Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

CompletedNCT02281136

DUSA Pharmaceuticals, Inc.Keratosis, Actinic

Start: 2014-12-31End: 2015-04-30Updated: 2017-01-13

Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

CompletedNCT02628236

DUSA Pharmaceuticals, Inc.Keratosis, Actinic

Start: 2016-02-29End: 2016-07-31Updated: 2017-09-18

Related Papers

A Randomized Trial of Broad Area ALA–PDT for Field Cancerization Mitigation in High-Risk Patients

Journal of Drugs in Dermatology2020-04-016 citations